Results 161 to 170 of about 382,920 (355)

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

Cancer, 1975
B. Durie, S. Salmon
semanticscholar   +1 more source

Hematopoietic Stem Cell Transplantation in Multiple Myeloma in the Era of Novel Therapies

, 2019
Khalid Ahmed Al‐Anazi
openalex   +2 more sources

Targeted inhibition of the immunoproteasome is a potent strategy against models of multiple myeloma that overcomes resistance to conventional drugs and nonspecific proteasome inhibitors [PDF]

, 2008
Deborah J. Kuhn, Sally A. Hunsucker, Qing Chen, Peter M. Voorhees, Marian Orłowski, Robert Z. Orlowski   +5 more
openalex   +1 more source

Longitudinal Swallowing and Salivary Changes With CLR 131 and Re‐Irradiation in Recurrent Head and Neck Cancer

Head &Neck, EarlyView.
ABSTRACT Background Patients with recurrent head and neck cancer (HNC) often present with severe, persistent dysphagia and xerostomia following prior chemoradiation. Although swallowing impairments and salivary dysfunction have been reported in this population, prior longitudinal studies have not examined changes in salivary composition or how these ...
Jenni Wu, Sara Gustafson, Meredith Hyun, Roxana Alexandridis, Mark Nicosia, Timothy McCulloch, Justine Bruce, Randall Kimple, Nicole Rogus‐Pulia   +8 more
wiley   +1 more source

Peer Review #1 of "Involvement of the arachidonic acid cytochrome P450 epoxygenase pathway in the proliferation and invasion of human multiple myeloma cells (v0.2)"

, 2016
D Bishop-Bailey
openalex   +1 more source

Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma.

New England Journal of Medicine, 2016
M. Dimopoulos, A. Oriol, H. Nahi, J. San-Miguel, N. Bahlis, S. Usmani, N. Rabin, R. Orlowski, M. Komarnicki, Kenshi Suzuki, T. Plesner, S. Yoon, D. Ben Yehuda, P. Richardson, H. Goldschmidt, D. Reece, S. Lisby, N. Khokhar, L. O’Rourke, Christopher Chiu, X. Qin, Mary E. Guckert, T. Ahmadi, P. Moreau   +23 more
semanticscholar   +1 more source

Where Is the 'Oma' in Multiple Myeloma? Origins and Limitations of some Myeloma-Related Terminology. [PDF]

EJHaem
Thachil J, Steensma DP.
europepmc   +1 more source

Immunological Deficiency Disorders Associated with Chronic Lymphocytic Leukemia and Multiple Myeloma* [PDF]

, 1964
Lawrence A. Cone, Jonathan W. Uhr
openalex   +1 more source

Current Therapeutic Strategies and New Drug Development in Multiple Myeloma

, 2021
Kiyoshi Okazuka
openalex   +2 more sources

Cardiovascular disease incidence and cancer risk in two large European prospective cohorts

International Journal of Cancer, EarlyView.
What's New? Cardiovascular disease (CVD) and cancer share risk factors and biological mechanisms, raising questions about potential associations between the two, particularly regarding CVD duration and cancer onset. Whether CVD influences subsequent cancer risk, however, remains inconclusive.
Emma Fontvieille, Vivian Viallon, Laia Peruchet‐Noray, Quan Gan, N. Charlotte Onland‐Moret, Yvonne Koop, Anne Tjønneland, Nicola Patricia Bondonno, Verena Katzke, Rudolf Kaaks, Matthias B. Schulze, Catarina Schiborn, Calogero Saieva, Vittorio Simeon, Claudia Agnoli, Rosario Tumino, Fulvio Ricceri, Leila Luján‐Barroso, Maria‐José Sánchez, Conchi Moreno‐Iribas, Konstantinos K. Tsilidis, Marc J. Gunter, Adam Butterworth, Elio Riboli, Heinz Freisling, Pietro Ferrari   +25 more
wiley   +1 more source